Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Proietti

Showing results (11-20 of 280) with videos related to

Pageof 28
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 5, 2019
Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant DrugsMarco Proietti, Giuseppe Boriani
Advances in Experimental Medicine and Biology|January 3, 2020
Frailty: What Is It?Marco Proietti, Matteo Cesari
European Journal of Internal Medicine|August 4, 2019
Screening for atrial fibrillation: Need for an integrated, structured approachGiuseppe Boriani, Marco Proietti
Experimental Gerontology|June 21, 2021
Describing the relationship between atrial fibrillation and frailty: Clinical implications and open research questionsMarco Proietti, Matteo Cesari
Heart (British Cardiac Society)|December 2, 2017
Atrial fibrillation prevention: an appraisal of current evidenceGiuseppe Boriani, Marco Proietti
Therapeutics and Clinical Risk Management|September 4, 2018
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisalMarco Proietti, Giuseppe Boriani
Thrombosis and Haemostasis|July 30, 2021
Screening for Atrial Fibrillation in Relation to Stroke and Mortality RiskMarco Proietti, Giuseppe Boriani
Chest|May 22, 2021
Management of Ventricular Heart Rate in Atrial Fibrillation Patients With SepsisMarco Proietti, Giulio Francesco Romiti
Circulation. Cardiovascular Quality and Outcomes|August 21, 2024
Impact of Frailty Dynamics in Patients With Atrial Fibrillation: Learning How Clinical Complexity Increases Risk in Cardiovascular DiseasesGiulio Francesco Romiti, Marco Proietti
International Journal of Cardiology|March 13, 2017
Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trialsMarco Proietti, Gregory Yh Lip
Pageof 28

Showing results (11-20 of 280) with videos related to

Sort By:
Pageof 28
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 5, 2019
Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant DrugsMarco Proietti, Giuseppe Boriani
Advances in Experimental Medicine and Biology|January 3, 2020
Frailty: What Is It?Marco Proietti, Matteo Cesari
European Journal of Internal Medicine|August 4, 2019
Screening for atrial fibrillation: Need for an integrated, structured approachGiuseppe Boriani, Marco Proietti
Experimental Gerontology|June 21, 2021
Describing the relationship between atrial fibrillation and frailty: Clinical implications and open research questionsMarco Proietti, Matteo Cesari
Heart (British Cardiac Society)|December 2, 2017
Atrial fibrillation prevention: an appraisal of current evidenceGiuseppe Boriani, Marco Proietti
Therapeutics and Clinical Risk Management|September 4, 2018
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisalMarco Proietti, Giuseppe Boriani
Thrombosis and Haemostasis|July 30, 2021
Screening for Atrial Fibrillation in Relation to Stroke and Mortality RiskMarco Proietti, Giuseppe Boriani
Chest|May 22, 2021
Management of Ventricular Heart Rate in Atrial Fibrillation Patients With SepsisMarco Proietti, Giulio Francesco Romiti
Circulation. Cardiovascular Quality and Outcomes|August 21, 2024
Impact of Frailty Dynamics in Patients With Atrial Fibrillation: Learning How Clinical Complexity Increases Risk in Cardiovascular DiseasesGiulio Francesco Romiti, Marco Proietti
International Journal of Cardiology|March 13, 2017
Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trialsMarco Proietti, Gregory Yh Lip
Pageof 28